Inhibition of proteasome, apoptosis and sensitization to tumour necrosis factor alpha: do they always go together?
Stokłosa
T
T
Wójcik
C
C
Gołab
J
J
Giermasz
A
A
Wilk
S
S
D000111:Acetylcysteine / Q000031:analogs & derivatives* / Q000494:pharmacology; D000447:Aldehydes / Q000494:pharmacology; D000818:Animals; D017209:Apoptosis; D015853:Cysteine Proteinase Inhibitors / Q000494:pharmacology*; D006801:Humans; D007939:Leukemia L1210; D008546:Melanoma, Experimental; D014407:Tumor Cells, Cultured / Q000187:drug effects; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*
D000447:Aldehydes; D015853:Cysteine Proteinase Inhibitors; D014409:Tumor Necrosis Factor-alpha; C067713:lactacystin; D000111:Acetylcysteine